ARC Group WorldWide Inc  

(Public, NASDAQ:ARCW)   Watch this stock  
Find more results for ARCW
16.21
+0.59 (3.78%)
Oct 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.50 - 16.50
52 week 2.48 - 25.00
Open 15.51
Vol / Avg. 56,056.00/77,198.00
Mkt cap 232.86M
P/E 40.58
Div/yield     -
EPS 0.40
Shares 14.91M
Beta 0.86
Inst. own 6%
Oct 8, 2014
Q4 2014 ARC Group Worldwide Inc Earnings Call - 5:00PM EDT - Add to calendar
Oct 8, 2014
Q4 2014 ARC Group Worldwide Inc Earnings Release - 4:00PM EDT - Add to calendar
Sep 18, 2014
ARC Group Worldwide Inc at Imperial Capital Global Opportunities Conference
Sep 3, 2014
ARC Group Worldwide Inc at Brean Capital Global Technology Conference
Aug 14, 2014
ARC Group Worldwide Inc at Canaccord Genuity Growth Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 7.88% 5.26%
Operating margin 15.64% 7.91%
EBITD margin - 14.70%
Return on average assets 9.40% 9.12%
Return on average equity 21.69% 18.27%
Employees 442 -
CDP Score - -

Address

7040 COUNTY ROAD 20
LONGMONT, CO 80504
United States - Map
+1-386-7364890 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ARC Group Worldwide, Inc is a global advanced manufacturing and third dimensional (3D) printing service provider. The Company offers its customers a portfolio of manufacturing technologies and capabilities. The Company has expertise in 3D printing and imaging, advanced tooling, automation, machining, plastic injection molding, lean manufacturing, and robotics.

Officers and directors

Jason T. Young Chairman of the Board, President, Chief Executive Officer
Age: 34
Bio & Compensation  - Reuters
Drew M. Kelley Chief Financial Officer, Secretary, Director
Age: 37
Bio & Compensation  - Reuters
Todd Grimm Independent Director
Bio & Compensation  - Reuters
Eddie W. Neely Independent Director
Age: 62
Bio & Compensation  - Reuters
Gregory D. Wallis Independent Director
Age: 54
Bio & Compensation  - Reuters